Genocea Biosciences (NASDAQ:GNCA) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Genocea Biosciences ( NASDAQ:GNCA – Free Report ) in a research note issued to investors on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock.

Genocea Biosciences Price Performance The company has a debt-to-equity ratio of 0.24, a current ratio of 1.35 and a quick ratio of 1.



35. The firm has a market cap of $6,000.00, a price-to-earnings ratio of 0.

00 and a beta of 1.61. Genocea Biosciences has a one year low of $0.

00 and a one year high of $0.00. Genocea Biosciences Company Profile ( Get Free Report ) Further Reading Receive News & Ratings for Genocea Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genocea Biosciences and related companies with MarketBeat.

com's FREE daily email newsletter ..